Your browser doesn't support javascript.
loading
How Effective Is Misoprostol Alone for Medication Abortion?
Moseson, Heidi; Jayaweera, Ruvani; Baum, Sarah E; Gerdts, Caitlin.
Afiliação
  • Moseson H; Ibis Reproductive Health, Oakland, CA.
  • Jayaweera R; Ibis Reproductive Health, Oakland, CA.
  • Baum SE; Ibis Reproductive Health, Oakland, CA.
  • Gerdts C; Ibis Reproductive Health, Oakland, CA.
NEJM Evid ; 3(6): EVIDccon2300129, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38804786
ABSTRACT
AbstractWith recent severe restrictions to abortion accessibility in the United States and a pending Supreme Court case challenging the Food and Drug Administration's approval of mifepristone, evidence-based strategies to protect and expand access to abortion care are needed. Two safe and effective regimens for medication abortion are widely used globally - misoprostol-only and misoprostol in combination with mifepristone. However, misoprostol-only regimens are rarely used in the United States. In 2023, the National Abortion Federation and the Society of Family Planning updated their recommended protocol for misoprostol-only for medication abortion to 800 µg of misoprostol administered buccally, sublingually, or vaginally every 3 hours for three or more doses. To characterize the data supporting this specific regimen, this article reviews the relevant literature to address the question of how effective misoprostol-only is for medication abortion. The authors conclude that the updated misoprostol regimen is highly effective and a potential strategy for expanding access to abortion.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Abortivos não Esteroides / Mifepristona / Misoprostol / Aborto Induzido Limite: Female / Humans / Pregnancy País como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Abortivos não Esteroides / Mifepristona / Misoprostol / Aborto Induzido Limite: Female / Humans / Pregnancy País como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article